Orthopaedic applications of gene therapy: From concept to clinic

R. Kang, S. C. Ghivizzani, T. S. Muzzonigro, J. H. Herndon, P. D. Robbins, Christopher H Evans

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Gene therapy offers new possibilities for the clinical management of orthopaedic conditions that are difficult to treat by traditional surgical or medical means. To bring the potential of this novel technology into the clinic, a research program was initiated that aimed to identify orthopaedically useful genes and develop methods for delivering them to suitable sites under conditions in which gene expression remains at therapeutic levels for the appropriate periods of time; this program is now 10 years old. Rheumatoid arthritis was selected as the lead disease. Preclinical studies evaluating the local and systemic delivery of numerous different genes by in vivo and ex vivo methods in murine and lapin models led to the development of a human gene therapy protocol for arthritis. In this protocol, a gene encoding the human interleukin-1 receptor antagonist protein is transferred to the metacarpophalangeal joints of female patients with rheumatoid arthritis. The first patient was treated this way in July 1996. This is not only the first orthopaedic application of human gene therapy, but also the first use of gene therapy approved for a nonlethal disease. In addition to providing additional therapeutic options for the treatment of rheumatoid arthritis, the experimental data from this study suggest that gene transfer approaches may improve the treatment of osteoarthritis, the repair of cartilage, ligaments, tendons, menisci, intervertebral discs and bone, and the management of disorders such as osteoporosis and osteogenesis imperfecta. They also show promise as a means for developing novel and improved animal models of orthopaedic diseases. If the current rate of progress continues, wide clinical application of gene therapy in various orthopaedic indications should occur within the next 5 to 10 years.

Original languageEnglish (US)
Pages (from-to)324-337
Number of pages14
JournalClinical Orthopaedics and Related Research
Issue number375
StatePublished - 2000
Externally publishedYes

Fingerprint

Genetic Therapy
Orthopedics
Rheumatoid Arthritis
Genes
Metacarpophalangeal Joint
Animal Disease Models
Osteogenesis Imperfecta
Intervertebral Disc
Human Development
Therapeutics
Ligaments
Osteoarthritis
Tendons
Osteoporosis
Arthritis
Cartilage
Technology
Gene Expression
Bone and Bones
Research

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

Kang, R., Ghivizzani, S. C., Muzzonigro, T. S., Herndon, J. H., Robbins, P. D., & Evans, C. H. (2000). Orthopaedic applications of gene therapy: From concept to clinic. Clinical Orthopaedics and Related Research, (375), 324-337.

Orthopaedic applications of gene therapy : From concept to clinic. / Kang, R.; Ghivizzani, S. C.; Muzzonigro, T. S.; Herndon, J. H.; Robbins, P. D.; Evans, Christopher H.

In: Clinical Orthopaedics and Related Research, No. 375, 2000, p. 324-337.

Research output: Contribution to journalArticle

Kang, R, Ghivizzani, SC, Muzzonigro, TS, Herndon, JH, Robbins, PD & Evans, CH 2000, 'Orthopaedic applications of gene therapy: From concept to clinic', Clinical Orthopaedics and Related Research, no. 375, pp. 324-337.
Kang R, Ghivizzani SC, Muzzonigro TS, Herndon JH, Robbins PD, Evans CH. Orthopaedic applications of gene therapy: From concept to clinic. Clinical Orthopaedics and Related Research. 2000;(375):324-337.
Kang, R. ; Ghivizzani, S. C. ; Muzzonigro, T. S. ; Herndon, J. H. ; Robbins, P. D. ; Evans, Christopher H. / Orthopaedic applications of gene therapy : From concept to clinic. In: Clinical Orthopaedics and Related Research. 2000 ; No. 375. pp. 324-337.
@article{7077005829704dce94d1e147e0ae5a38,
title = "Orthopaedic applications of gene therapy: From concept to clinic",
abstract = "Gene therapy offers new possibilities for the clinical management of orthopaedic conditions that are difficult to treat by traditional surgical or medical means. To bring the potential of this novel technology into the clinic, a research program was initiated that aimed to identify orthopaedically useful genes and develop methods for delivering them to suitable sites under conditions in which gene expression remains at therapeutic levels for the appropriate periods of time; this program is now 10 years old. Rheumatoid arthritis was selected as the lead disease. Preclinical studies evaluating the local and systemic delivery of numerous different genes by in vivo and ex vivo methods in murine and lapin models led to the development of a human gene therapy protocol for arthritis. In this protocol, a gene encoding the human interleukin-1 receptor antagonist protein is transferred to the metacarpophalangeal joints of female patients with rheumatoid arthritis. The first patient was treated this way in July 1996. This is not only the first orthopaedic application of human gene therapy, but also the first use of gene therapy approved for a nonlethal disease. In addition to providing additional therapeutic options for the treatment of rheumatoid arthritis, the experimental data from this study suggest that gene transfer approaches may improve the treatment of osteoarthritis, the repair of cartilage, ligaments, tendons, menisci, intervertebral discs and bone, and the management of disorders such as osteoporosis and osteogenesis imperfecta. They also show promise as a means for developing novel and improved animal models of orthopaedic diseases. If the current rate of progress continues, wide clinical application of gene therapy in various orthopaedic indications should occur within the next 5 to 10 years.",
author = "R. Kang and Ghivizzani, {S. C.} and Muzzonigro, {T. S.} and Herndon, {J. H.} and Robbins, {P. D.} and Evans, {Christopher H}",
year = "2000",
language = "English (US)",
pages = "324--337",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "375",

}

TY - JOUR

T1 - Orthopaedic applications of gene therapy

T2 - From concept to clinic

AU - Kang, R.

AU - Ghivizzani, S. C.

AU - Muzzonigro, T. S.

AU - Herndon, J. H.

AU - Robbins, P. D.

AU - Evans, Christopher H

PY - 2000

Y1 - 2000

N2 - Gene therapy offers new possibilities for the clinical management of orthopaedic conditions that are difficult to treat by traditional surgical or medical means. To bring the potential of this novel technology into the clinic, a research program was initiated that aimed to identify orthopaedically useful genes and develop methods for delivering them to suitable sites under conditions in which gene expression remains at therapeutic levels for the appropriate periods of time; this program is now 10 years old. Rheumatoid arthritis was selected as the lead disease. Preclinical studies evaluating the local and systemic delivery of numerous different genes by in vivo and ex vivo methods in murine and lapin models led to the development of a human gene therapy protocol for arthritis. In this protocol, a gene encoding the human interleukin-1 receptor antagonist protein is transferred to the metacarpophalangeal joints of female patients with rheumatoid arthritis. The first patient was treated this way in July 1996. This is not only the first orthopaedic application of human gene therapy, but also the first use of gene therapy approved for a nonlethal disease. In addition to providing additional therapeutic options for the treatment of rheumatoid arthritis, the experimental data from this study suggest that gene transfer approaches may improve the treatment of osteoarthritis, the repair of cartilage, ligaments, tendons, menisci, intervertebral discs and bone, and the management of disorders such as osteoporosis and osteogenesis imperfecta. They also show promise as a means for developing novel and improved animal models of orthopaedic diseases. If the current rate of progress continues, wide clinical application of gene therapy in various orthopaedic indications should occur within the next 5 to 10 years.

AB - Gene therapy offers new possibilities for the clinical management of orthopaedic conditions that are difficult to treat by traditional surgical or medical means. To bring the potential of this novel technology into the clinic, a research program was initiated that aimed to identify orthopaedically useful genes and develop methods for delivering them to suitable sites under conditions in which gene expression remains at therapeutic levels for the appropriate periods of time; this program is now 10 years old. Rheumatoid arthritis was selected as the lead disease. Preclinical studies evaluating the local and systemic delivery of numerous different genes by in vivo and ex vivo methods in murine and lapin models led to the development of a human gene therapy protocol for arthritis. In this protocol, a gene encoding the human interleukin-1 receptor antagonist protein is transferred to the metacarpophalangeal joints of female patients with rheumatoid arthritis. The first patient was treated this way in July 1996. This is not only the first orthopaedic application of human gene therapy, but also the first use of gene therapy approved for a nonlethal disease. In addition to providing additional therapeutic options for the treatment of rheumatoid arthritis, the experimental data from this study suggest that gene transfer approaches may improve the treatment of osteoarthritis, the repair of cartilage, ligaments, tendons, menisci, intervertebral discs and bone, and the management of disorders such as osteoporosis and osteogenesis imperfecta. They also show promise as a means for developing novel and improved animal models of orthopaedic diseases. If the current rate of progress continues, wide clinical application of gene therapy in various orthopaedic indications should occur within the next 5 to 10 years.

UR - http://www.scopus.com/inward/record.url?scp=0034119863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034119863&partnerID=8YFLogxK

M3 - Article

C2 - 10853185

AN - SCOPUS:0034119863

SP - 324

EP - 337

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 375

ER -